company's propriety issue?

Recently, in order to reduce the time and effort to design and optimized an real-time PCR or qPCR assay, lots of scientist opts for pre-designed assay from certain company (s).

These assays are indeed helps a lot of scientist by reducing their time and effort to design their own assay where they need to consider the primer (s) and/ or probe (s) specificity and efficiency, mispriming and etc.

However, one of the common issues faced by the scientist when they wish to publish their data using these assays is due to the company's propriety issue, the sequence information for the primer (s) and probe (s) can not be disclosed. But these information is critical as it is required by MIQE guidelines.

So now, does these companies still want to keep these information to themselves, which might affect the sales of these assay (in my opinion) or just do the customer a favor by disclosing these information so that there are more citation for these assay in near future??????